Publications by authors named "Timo Siitonen"

Claim this Profile
B
Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial.
Mika Kontro, Anthony Selwyn Stein, Marja Pyörälä, Johanna Rimpiläinen, Timo Siitonen

Lancet Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching From Standard to Extended Half-Life Coagulation Factor Replacement in Haemophilia: Clinical Outcomes and Costs of Care in Finland.
Mirkka Koivusalo, Timea Szanto, Tuomas Kovalainen, Aino Vesikansa, Outi Laine, Timo Siitonen

Haemophilia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multicentre Trial.
Sari Kytölä, Mika Kurkela, Johanna I Kiiski, Ida Vänttinen, Tanja Ruokoranta, Timo Siitonen

Basic Clin Pharmacol Toxicol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial.
Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta, Anu Partanen, Annasofia Holopainen, Timo Siitonen

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia.
Heikki Kuusanmäki, Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta, Amanda Ranta, Sanna Siitonen, Timo Siitonen

Haematologica· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.
Marja Hakkarainen, Ilse Kaaja, Suvi P M Douglas, Tom Vulliamy, Inderjeet Dokal, Timo Siitonen

Blood· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the number of cryopreserved CD34 cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.
Anu Partanen, Antti Turunen, Raija Silvennoinen, Jaakko Valtola, Marja Pyörälä, Timo Siitonen

J Clin Apher· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Helena Hohtari, Niels Pallisgaard, Matti Kankainen, Pekka Ellonen, Oscar Brück, Timo Siitonen

Haematologica· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of CD34 cell mobilization, blood graft cellular composition, and post-transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low-dose cyclophosphamide: A prospective multicenter study.
Partanen Anu, Turunen Antti, Silvennoinen Raija, Pyörälä Marja, Valtola Jaakko, Siitonen Timo

Transfusion· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.
Antti Turunen, Raija Silvennoinen, Anu Partanen, Jaakko Valtola, Timo Siitonen

Transfusion· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of healthcare utilisation and cost of haemophilia care in real-life: A 4-year follow-up study in Finland.
Hanna Ventola, Aino Vesikansa, Jari Jokelainen, Timo Siitonen, Pia Ettala

Haemophilia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.
Antti Turunen, Anu Partanen, Jaakko Valtola, Antti Ropponen, Timo Siitonen

Transfusion· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.
Sini Luoma, Pekka Anttila, Marjaana Säily, Tuija Lundan, Jouni Heiskanen, Timo Siitonen

Ann Hematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study.
Jaakko Valtola, Raija Silvennoinen, Antti Ropponen, Timo Siitonen, Marjaana Säily

Leuk Lymphoma· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia.
Michela Faleschini, Federica Melazzini, Caterina Marconi, Tania Giangregorio, Tommaso Pippucci, Timo Siitonen

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADA2 deficiency: Clonal lymphoproliferation in a subset of patients.
Luca Trotta, Timi Martelius, Timo Siitonen, Timo Hautala, Sari Hämäläinen

J Allergy Clin Immunol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lenalidomide-based induction therapy on the mobilization of CD34 cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.
Anu Partanen, Jaakko Valtola, Raija Silvennoinen, Antti Ropponen, Timo Siitonen

Transfusion· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.
Jaakko Valtola, Raija Silvennoinen, Antti Ropponen, Timo Siitonen, Marjaana Säily

Transfusion· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Candida krusei isolates remain susceptible during extensive exposure to antifungal drugs.
Timo Hautala, Sakari Kakko, Timo Siitonen, Marjaana Säily, Pirjo Koistinen

Med Mycol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid combined with 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 in the treatment of patients with myelodysplastic syndromes.
Timo Siitonen, Timo Timonen, Eeva Juvonen, Venla Terävä, Anu Kutila

Haematologica· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cluster of Candida krusei infections in a haematological unit.
Timo Hautala, Irma Ikäheimo, Heidi Husu, Marjaana Säily, Timo Siitonen

BMC Infect Dis· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
Pirjo Koistinen, Riikka Räty, Maija Itälä, Esa Jantunen, Elli Koivunen, Timo Siitonen

Eur J Haematol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An association between manganese superoxide dismutase polymorphism and outcome of chemotherapy in acute myeloid leukemia.
Pirjo Koistinen, Satu Ruuska, Marjaana Saily, Sakari Kakko, Pauliina Siitonen, Timo Siitonen

Haematologica· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27(Kip 1) in acute myeloblastic leukemia cells.
Timo Siitonen, Pirjo Koistinen, Eeva-Riitta Savolainen

Leuk Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prophylactic platelet transfusion in patients with hematologic diseases].
Timo Siitonen, Pirjo Koistinen

Duodecim· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis